Uptake and gene expression with antitumoral doses of iodine in thyroid and mammary gland: Evidence that chronic administration has no harmful effects

Thyroid

Volumn 17, Issue 9, 2007, Pages 851-859

  Anguiano, Brenda ^a   García Solís, Pablo ^a   Delgado, Guadalupe ^a   Velasco, Carmen Aceves ^a,b  

^a CENTRO DE FÍSICA APLICADA Y TECNOLOGÍA AVANZADA   (Mexico)

^b INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; FUROSEMIDE; IODINE; IODINE 125; LIOTHYRONINE; MESSENGER RNA; METHYLNITROSOUREA; PERCHLORATE; POTASSIUM IODIDE; THIAMAZOLE; THYROID PEROXIDASE; THYROTROPIN; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER THERAPY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG UPTAKE; FEMALE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIOTHYRONINE BLOOD LEVEL; LONG TERM EXPOSURE; MAMMARY GLAND; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; THYROID FUNCTION; THYROXINE BLOOD LEVEL;

ANIMALS; CHLORIDE-BICARBONATE ANTIPORTERS; FEMALE; GENE EXPRESSION; IODIDE PEROXIDASE; IODINE; IODINE RADIOISOTOPES; LACTOPEROXIDASE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; SYMPORTERS; THYROID GLAND; THYROID HORMONES;

EID: 35348996441     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0122     Document Type: Article

References (40)

1. World Health Organization (WHO), United Nations Children's Fund (UNICEF), International Council for Control of Iodine Deficiency Disorders (ICCIDD) 1999 Progress Towards the Elimination of Iodine Deficiency Disorders (IDD). WHO booklet, pp 1-33.
2. Cann SA, van Netten JP, Glover DW, van Netten C 1999 Iodide accumulation in extrathyroidal tissues. J Clin Endocrinol Metab 84:821-822.
3. Smyth PP 2003 Role of iodine in antioxidant defence in thyroid and breast disease. Biofactors 19:121-130.
4. Venturi S, Donati FM, Venturi A, Venturi M, Grossi L, Guidi A 2000 Role of iodine in evolution and carcinogenesis of thyroid, breast and stomach. Adv Clin Path 4:11-17.
5. Thrall KD, Bull RJ, Sauer RL 1992 Distribution of iodine into blood components of the Sprague-Dawley rat differs with the chemical form administered. J Toxicol Environ Health 37:443-449.
6. Eskin BA, Grotkowski CE, Connolly CP, Ghent WR 1995 Different tissue responses for iodine and iodide in rat thyroid and mammary glands. Biol Trace Elem Res 49:9-19.
7. Ghent WR, Eskin BA, Low DA, Hill LP 1993 Iodine replacement in fibrocystic disease of the breast. Can J Surg 36:453-460.
8. Kessler JH 2004 The effect of supraphysiologic levels of iodine on patients with cyclic mastaglia. Breast J 10:328-336.
9. Funahashi H, Imai T, Tanaka Y, Tobinaga J, Wada M, Morita T, Yamada F, Tsukamura K, Oiwa M, Kikumori T, Narita T, Takagi H 1996 Suppressive effect of iodine on DMBA-induced breast tumor growth in the rat. J Surg Oncol 61:209-213.
10. 2 prevents cancer promotion. Mol Cell Endocrinol 236:49-57.
11. Arroyo-Helguera O, Anguiano B, Delgado G Aceves C 2006 Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line. Endocr Relat Cancer 13:1147-1158.
12. Shrivastava A, Tiwari M, Sinha RA, Kumar A, Balapure AK, Bajpai VK, Sharma R, Mitra K, Tandon A, Godbole MM 2006 Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving mitochondria-mediated pathway. J Biol Chem 281:19762-19771.
13. Burgui H, Schaffner TH, Seller JP 2001 The toxicology of iodate: a review of the literature. Thyroid 11:449-456.
14. Markou K, Georgopoulos N, Kyriazopoulou V, Vangenakis AG 2001 Iodine-induced hypothyroidism. Thyroid 11:501-510.
15. Robison LM, Sylvester PW, Bikenfeld P, Lang JP, Bull RJ 1998 Comparison of the effects of iodine and iodide on thyroid function in humans. J Toxicol Environ Heatlh A 55:93-106.
16. Morton ME, Chaikoff IL, Rosenfeld S 1944 Inhibiting effect of inorganic iodide on the formation in vitro of thyroxine and diiodotyrosine by surviving thyroid tissue. J Biol Chem 154:381-387.
17. Paul T, Meyers B, Witorch RJ, Pino S, Chipkin S, Ingbar SH, Braverman LE 1988 The effect of small increases in dietary iodine on thyroid function in euthyroid subjects. Metabolism 37:121-124.
18. Wolff J, Chaikoff IL 1948 Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 154:555-564.
19. Eng PHK, Cardona GR, Fang SL, Previti M, Alex S, Carrasco N, Chin WW, Braverman LE 1999 Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140:3404-3410.
20. Uyttersprot N, Pelgrins N, Carrasco N, Gervy C, Maenhaut C, Dumont JE, Miot F 1997 Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and NaI symporter mRNA in dog thyroid. Mol Cell Endocrinol 131:195-203.
21. Pisarev MA, Gartner R 2000 Autoregulatory actions of iodine. In: Braverman E, Utiger R (eds) Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. Lippincott Williams and Wilkins, Philadelphia, pp 85-90.
22. Morand S, Chaaraoui M, Kaniewski J, Deme D, Ohayon R, Noel-Hudson MS, Virion A, Dupuy C 2003 Effect of iodide on nicotinamide adenine dinucleotide phosphate oxidase activity and Duox2 protein expression in isolated porcine thyroid follicles. Endocrinology 144:1241-1248.
23. Wenzel A, Upadhyay G, Schmitt TL, Loos U 2003 Iodination of proteins in TPO transfected thyroid cancer cells is independent of NIS. Mol Cell Endocrinol 213:99-108.
24. Gillan MP, Sidhave AR, Lee EJ, Rutishauser J, Stephan CW, Kopp P 2004 Functional characterization of pendrin in a polarized cell system. Evidence for pendrin-mediated apical iodide efflux. J Biol Chem 279:13004-13010.
25. Skubis-Zegadlo J, Nikodemska A, Przytula E, Mikula M, Bardadin K, Ostrowski J, Wenzel BE, Czarnocka B 2005 Expression of pendrin in benign and malignant human thyroid tissues. Br J Cancer 93:144-151.
26. Rillema JA, Hill MA 2003 Pendrin transporter carries out iodide uptake into MCF-7 human mammary cancer cells. Exp Biol Med 228:1078-1082.
27. Thompson HJ 2000 Methods for the induction of mammary carcinogenesis in the rat using either 7,12-dimethylbenz[a]-antracene or 1-methyl-1-nitrosourea. In: Ip M, Asch BB (eds) Methods in Mammary Gland Biology and Breast Cancer Research, 8th. Kluwer Academic/Plenum Publishers, New York, pp 19-29.
28. Heige S, Pfaffl MW 2006 RNA integrity and the effect on real-time qRT-PCR performance. Mol Aspects Med 27:126-139.
29. Aceves C, Rodón C, Ramírez-C I, Wilson S, Pineda O, López-BL, Mancilla R, Valverde-RC 1995 Mammary 5′-deiodinase (5′D) during the breeding cycle of the rat: indirect evidence that 5′D type I is specific to the alveolar epithelium. Endocrine 3:95-99.
30. Valverde-R C, Aceves C 1989 Circulating thyronines and peripheral monodeiodination in lactating rats. Endocrinology 124:1340-1344.
31. Ohasawa K, Yoshimura Y, Watanabe S, Tanaka H, Yokota A, Tamura K, Imaeda K 1986 Determination of xylitol in human serum and saliva by ion chromatography with pulsed amperometric detection. Anal Sci 2:165-168.
32. Bruchertseifer H, Cripps R, Guentay S, Jaeckel B 2003 Analysis of iodine species in aqueous solutions. Anal Bioanal Chem 375:1107-1110.
33. Delgado G, Muñoz-Torres C, Orozco-Esquivel T, Aceves C 2006 Desarrollo de una metodologia cromatografica para la cuantificacion de yodo en diferentes formas quimicas y fluidos biologicos. Jornadas del Instituto de Neurobiologia, UNAM, México, pp 63.
34. Küpper FC, Schweigert N, Ar Cali E, Legendre JM, Vilter H, Koareg B 1998 Iodine uptake in laminariales involves extracellular, haloperoxidase- mediated oxidation of iodide. Planta 207:163-171.
35. Thrall KD, Sauer R, Bull RJ 1992 Evidence of thyroxine formation following iodine administration in Sprague-Dawley rats. J Toxicol Environ Health 37:535-548.
36. Dugrillon A, Bechtner G, Uedelhoven WM, Weber PC, Gartner T 1990 Evidence that an iodolactone mediates the inhibitory effect of iodide on thyroid cell proliferation but not on adenosine 3′-5′-monophosphate formation. Endocrinology 127:337-343.
37. Pisarev MA, Krawiec L, Juvenal GJ, Bocanera LV, Pregliasco LB, Sartorio G, Chester HA 1994 Studies on the goiter inhibiting action of iodolactones. Eur J Pharmacol 258:33-37.
38. Langer R, Burzler C, Bechtner G, Gartner R 2003 Influence of iodide and iodolactones on thyroid apoptosis. Exp Clin Endocrinol Diabetes 111:325-329.
39. Tan WC, Privett OS, Goldyne ME 1974 Studies of prostaglandins in rat mammary tumors induced by 7,12-dymethyl-benz(a)anthracene. Cancer Res 34:3229-3231.
40. Rolland PH, Martin PM, Jacquemier J, Rolland AM, Toga M 1980 Prostaglandins in human breast cancer: evidence suggesting that an elevated prostaglandins production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst 64:1061-1070.